Waga J
Department of Ophthalmology, University Hospital in Lund, Sweden.
Acta Ophthalmol Scand. 2000 Jun;78(3):369-71. doi: 10.1034/j.1600-0420.2000.078003369.x.
The treatment of cytomegalovirus retinitis has during the last years been done mainly with sustained release ganciclovir devices implanted in the vitreous. In the present study it is shown that ganciclovir can be administered into the rabbit vitreous by microdialysis. A concentration of about 10(-6) M, which is considered within the therapeutic range, is achieved in the vitreous after a microdialysis perfusion. The method offers possibility of variation in the drug delivery that is not possible with the ganciclovir implants.
在过去几年中,巨细胞病毒性视网膜炎的治疗主要是通过将缓释更昔洛韦装置植入玻璃体来进行的。在本研究中表明,更昔洛韦可通过微透析注入兔玻璃体。微透析灌注后,玻璃体中可达到约10⁻⁶M的浓度,该浓度被认为在治疗范围内。该方法提供了药物递送变化的可能性,这是更昔洛韦植入物所无法实现的。